Envestnet Asset Management Inc Neogenomics Inc Transaction History
Envestnet Asset Management Inc
- $326 Billion
- Q2 2025
A detailed history of Envestnet Asset Management Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 61,049 shares of NEO stock, worth $627,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,049
Previous 64,068
4.71%
Holding current value
$627,583
Previous $608,000
26.64%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NEO
# of Institutions
308Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$202 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$145 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$76.4 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$70.4 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$52.5 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.29B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...